A selective TSH receptor antagonist inhibits stimulation of thyroid function in female mice

Endocrinology

Volumn 155, Issue 1, 2014, Pages 310-314

  Neumann, Susanne ^a   Nir, Eshel A ^a   Eliseeva, Elena ^a   Huang, Wenwei ^b   Marugan, Juan ^b   Xiao, Jingbo ^b   Dulcey, Andrés E ^b   Gershengorn, Marvin C ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COTRANSPORTER; FOLLITROPIN; FOLLITROPIN RECEPTOR; HORMONE ANTAGONIST; LUTEINIZING HORMONE; PROTIRELIN; SODIUM IODIDE COTRANSPORTER; THYROID PEROXIDASE; THYROID STIMULATING IMMUNOGLOBULIN; THYROTROPIN; THYROTROPIN RECEPTOR; THYROTROPIN RECEPTOR ANTAGONIST; UNCLASSIFIED DRUG;

ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG EFFICACY; DRUG POTENCY; DRUG SELECTIVITY; FEMALE; FREE THYROXINE INDEX; GRAVES DISEASE; HORMONE INHIBITION; IC 50; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SINGLE DRUG DOSE; THYROID FUNCTION; THYROTROPIN RELEASE; TREATMENT DURATION;

EID: 84891409469     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2013-1835     Document Type: Article

References (18)

1. Davies TF, Ando T, Lin RY, Tomer Y, Latif R. Thyrotropin receptor-Associated diseases: from adenomata to Graves disease. J Clin Invest. 2005;115:1972-1983.
2. Emerson CH. When will thyrotropin receptor antagonists and inverse thyrotropin receptor agonists become available for clinical use Thyroid. 2011;21:817-819.
3. Sanders J, Miguel RN, Furmaniak J, Smith BR. TSH receptor monoclonal antibodies with agonist, antagonist, and inverse agonist activities. Methods Enzymol. 2010;485:393-420.
4. GershengornMC,NeumannS. Update inTSHreceptor agonists and antagonists. J Clin Endocrinol Metab. 2012;97:4287-4292.
5. Neumann S, Kleinau G, Costanzi S, et al. A low-molecular-weight antagonist for the human thyrotropin receptor with therapeutic potential for hyperthyroidism. Endocrinology. 2008;149:5945-5950.
6. Neumann S, Huang W, Eliseeva E, Titus S, Thomas CJ, Gershengorn MC. A small molecule inverse agonist for the human thyroidstimulating hormone receptor. Endocrinology. 2010;151:3454-3459.
7. Neumann S, Eliseeva E, McCoy JG, et al. A new small-molecule antagonist inhibits Graves' disease antibody activation of the TSH receptor. J Clin Endocrinol Metab. 2011;96:548-554.
8. Neumann S, Pope A, Geras-Raaka E, Raaka BM, Bahn RS, Gershengorn MC. A drug-like antagonist inhibits thyrotropin receptormediated stimulation of cAMP production in Graves' orbital fibroblasts. Thyroid. 2012;22:839-843.
9. Turcu AF, Kumar S, Neumann S, et al. A small molecule antagonist inhibits thyrotropin receptor antibody-induced orbital fibroblast functions involved in the pathogenesis of graves ophthalmopathy. J Clin Endocrinol Metab. 2013;98:2153-2159.
10. Van Koppen CJ, de Gooyer ME, Karstens WJ, et al. Mechanism of action of a nanomolar potent, allosteric antagonist of the thyroidstimulating hormone receptor. Br J Pharmacol. 2012;165:2314-2324.
11. van Zeijl CJ, Van Koppen CJ, Surovtseva OV, et al. Complete inhibition of rhTSH-, Graves' disease IgG-, and M22-induced cAMP production in differentiated orbital fibroblasts by a low-molecularweight TSHR antagonist. J Clin Endocrinol Metab. 2012;97:E781-E785.
12. Kleinau G, Krause G. Thyrotropin and homologous glycoprotein hormone receptors: structural and functional aspects of extracellular signaling mechanisms. Endocr Rev. 2009;30:133-151.
13. Neumann S, Huang W, Titus S, et al. Small molecule agonists for the thyrotropin receptor stimulate thyroid function in human thyrocytes and mice. Proc Natl Acad Sci USA. 2009;106:12471-12476.
14. Gullapalli R, Wong A, Brigham E, et al. Development of ALZET(R) osmotic pump compatible solvent compositions to solubilize poorly soluble compounds for preclinical studies. Drug Deliv. 2012;19: 239-246.
15. Hamidi S, Aliesky H, Chen CR, Rapoport B, McLachlan SM. Variable suppression of serum thyroxine in female mice of different inbred strains by triiodothyronine administered in drinking water. Thyroid. 2010;20:1157-1162.
16. Sanders J, Evans M, Premawardhana LD, et al. Human monoclonal thyroid stimulating autoantibody. Lancet. 2003;362:126-128.
17. Chen CR, McLachlan SM, Rapoport B. Suppression of thyrotropin receptor constitutive activity by a monoclonal antibody with inverse agonist activity. Endocrinology. 2007;148:2375-2382.
18. Bahn RS. Graves' ophthalmopathy. N Engl J Med. 2010;362:726-738.